Stockreport

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM [Yahoo! Finance]

Tenaya Therapeutics, Inc.  (TNYA) 
PDF Initial Data from Cohort 1 to be Reported in December 2024 Highlights Recently Presented Insights on Pediatric MYBPC3-associated HCM Disease Burden SOUTH SAN FRANCI [Read more]